Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D. Knight, Dashyant Dhanak, Cynthia A. Parrish et al.|ACS Medicinal Chemistry Letters|2010Cited by 374
Conformation-Dependent Ligand Regulation of ATP Hydrolysis by Human KSP: Activation of Basal Hydrolysis and Inhibition of Microtubule-Stimulated Hydrolysis by a Single, Small Molecule ModulatorLusong Luo, Robert A. Copeland, Jeffrey D. Carson et al.|Journal of the American Chemical Society|2008Cited by 16
Abstract C62: Identification of GSK2126458, a highly potent inhibitor of phosphoinositide 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR)Steven D. Knight, Dashyant Dhanak, Nicholas D. Adams et al.|Molecular Cancer Therapeutics|2009Cited by 4
Abstract C63: Biological characterization of GSK2126458, a novel and potent inhibitor of phosphoinositide 3-kinase and the mammalian target of rapamycin (mTOR)Mary Ann Hardwicke, Kurt R. Auger, Hong Lu et al.|Molecular Cancer Therapeutics|2009Cited by 1